Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure across the globe,...
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, announced...
ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics, announced that 1) dosing has...
A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou em 26/12/2022 o inibidor multiquinases Cabometyx® (levomalato de cabozantinibe) para o...
Second Clarifax received from Health Canada. MONTREAL, Dec. 22, 2022 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP)...
IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell...
Abbott (NYSE: ABT) today announced that its FreeStyle Libre® 3 sensor is now compatible with the mylife™ Loop solution from partners, Ypsomed and...
Sobi® and ADC Therapeutics SA today announced that the European Commission (EC) has granted conditional marketing authorisation for the use of...
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), und Pierre Fabre gaben heute bekannt, dass die Europäische Kommission (EC) die Zulassung für Ebvallo ®...
Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (Nasdaq : ATRA) et Pierre Fabre ont annoncé aujourd'hui que la Commission européenne (CE) a...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), y Pierre Fabre han anunciado hoy que la Comisión Europea (CE) ha concedido la autorización de...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), and Pierre Fabre today announced that the European Commission (EC) has granted marketing authorization...
Jacobio Pharma (1167. HK) announced that the Company's in-house KRAS G12C inhibitor JAB-21822 was granted breakthrough therapy designations for the...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has expanded the marketing authorization...
QurAlis Corporation, a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and...
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), empresa líder em terapias de RNAi, acaba de anunciar que a Agência Nacional de Vigilância Sanitária...
Novavax, Inc. (Nasdaq: NVAX), ein Biotechnologieunternehmen, das sich auf die Entwicklung und Vermarktung von Impfstoffen der nächsten Generation...
Novavax, Inc. (NASDAQ: NVAX), une société de biotechnologie qui se consacre au développement et à la commercialisation de vaccins de nouvelle...
A PTC Therapeutics, Inc. (NASDAQ: PTCT) anunciou hoje que a ANVISA (Agência Nacional de Vigilância Sanitária) aprovou o Waylivra™ (volanesorsen) como ...
PTC Therapeutics, Inc. (NASDAQ: PTCT) anunció hoy que la Agencia Nacional de Vigilancia Sanitaria de Brasil, ANVISA (Agência Nacional de Vigilância...
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), ...
Novavax, Inc. (Nasdaq: NVAX), una empresa de biotecnología dedicada al desarrollo y comercialización de vacunas de próxima generación para...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.